2025
Group annual financial statementsfor the year ended 30 September 2025

10 Cash flow
          Restated#
  (R'million)   2025   2024
10.1 Cash operating profit^        
  Profit before taxation from continuing operations   6 006   3 492
  Adjusted for:
  Depreciation and amortisation   857   922
  Loss on disposal of property, plant and equipment   5   14
  Early termination of leases   (9)   (6)
  Expected credit losses   (1)   (20)
  Share-based payments   115   71
  Provision movements:
  – Provisions for post-retirement medical aid   28   28
  – Accrued expenses charged to the income statement   733   385
  – Inventory provisions   72   17
  – Restructuring provision charges to operating profit   8   (9)
  Post-retirement medical aid buy-out   (1)   (1)
  Pension fund charged to income statement   1  
  Impairments and fair value loss/(gain)   20   (2)
  Non-operational items   (631)   (242)
  Non-operational items – advisory fees   (44)   (8)
  Net finance (income)/costs   (65)   287
  Foreign exchange (gain)/loss   (107)   49
  Realised foreign exchange gain   255  
  Investment income   (19)   (22)
  Income from associated companies   (376)   (724)
  Profit on disposal of associate   (996)  
  Impact of prior year product recall     15
  Cash operating profit – continuing operations   5 851   4 246
  Profit before taxation from discontinued operations   (272)   358
  Depreciation and amortisation   105   86
  Provision movements:
  – Accrued expenses charged to the income statement   (18)   (5)
  – Inventory provisions   46   (6)
  Impairments and loss on discontinuance   209   27
  Advisory fees   (6)  
  Net finance costs   9   7
  Foreign exchange (gain)/loss   (1)   2
  Cash operating profit – discontinued operations   72   469
  Cash operating profit – total operations   5 923   4 715
10.2 Working capital changes        
  Decrease in inventories   511   258
  (Increase)/decrease in trade and other receivables   (280)   338
  Increase in trade and other payables   955   150
  Working capital changes   1 186   746
10.3 Taxation paid
  Continuing operations
  Opening balance   35   (47)
  Current year taxation   (1 912)   (724)
  Deferred taxation   (54)   45
  Exchange rate differences and other non-cash items    
  Amounts payable/(receivable) at the end of the year   538   (35)
  Taxation paid – continuing operations   (1 393)   (761)
  Discontinued operations
  Opening balance   (37)   (48)
  Current year taxation – discontinued operations   29   (114)
  Deferred taxation – discontinued operations   (12)   16
  Exchange rate differences and other non-cash items   (13)   1
  Amounts payable at the end of the year   38   37
  Taxation received/(paid) – discontinued operations   5   (108)
  Taxation paid – total operations   (1 388)   (869)
10.4 Dividends paid        
  Per statement of changes in equity   (3 546)   (1 598)
  Dividends paid to outside shareholders   (2)   (3)
  Total dividends paid   (3 548)   (1 601)
10.5 Purchase of property, plant, equipment and intangible assets        
  Replacement   (252)   (461)
  Expansion   (937)   (509)
      (1 189)   (970)
10.6 Cash and cash equivalents at beginning of the year        
  Cash resources   1 625   844
  Short-term borrowings regarded as cash and cash equivalents   (245)  
      1 380   844
10.7 Cash and cash equivalents at end of the year        
  Cash resources   3 069   1 625
  Short-term borrowings regarded as cash and cash equivalents   (11)   (245)
  Discontinued operations (refer note 13)   169  
      3 227   1 380
  # Refer to note 12 for prior period restatements
  ^ Cash operating profit has been represented to reconcile to profit before taxation. In the prior year, cash operating profit was reconciled to operating profit before impairment and non-operational items